S&P 500   3,855.36
DOW   30,960.00
QQQ   328.11
S&P 500   3,855.36
DOW   30,960.00
QQQ   328.11
S&P 500   3,855.36
DOW   30,960.00
QQQ   328.11
S&P 500   3,855.36
DOW   30,960.00
QQQ   328.11
Log in

Adeptus Health Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
0.00 (0.00 %)
(As of 11/1/2017)
Today's Range
Now: $1.22
50-Day Range N/A
52-Week Range
Now: $1.22
Average Volume1.18 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Adeptus Health Inc. is a United States-base patient-centered healthcare company. The Company is engaged in providing emergency medical care through a network of independent freestanding emergency rooms in the United States and partnerships with various healthcare systems. It owns or operates facilities located in the Houston, Dallas/Fort Worth, San Antonio and Austin, Texas markets; Colorado Springs and Denver, Colorado markets, and Phoenix, Arizona market. Its radiology suites have in-house diagnostic imaging technology, including computerized tomography (CT) scanners, digital x-rays and ultrasounds, with final reads from on-call radiologists.


Overall MarketRank

0.40 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry N/A
Year FoundedN/A



Sales & Book Value

Annual SalesN/A



Next Earnings DateN/A
OptionableNot Optionable

Receive ADPTQ News and Ratings via Email

Sign-up to receive the latest news and ratings for ADPTQ and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Adeptus Health (OTCMKTS:ADPTQ) Frequently Asked Questions

What stocks does MarketBeat like better than Adeptus Health?

Wall Street analysts have given Adeptus Health a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Adeptus Health wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How were Adeptus Health's earnings last quarter?

Adeptus Health Inc. (OTCMKTS:ADPTQ) posted its quarterly earnings results on Thursday, July, 21st. The company reported $0.48 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.51 by $0.03. The business had revenue of $100.20 million for the quarter, compared to the consensus estimate of $93.92 million. The company's revenue was up 36.2% compared to the same quarter last year. During the same period in the previous year, the company earned $0.44 earnings per share.
View Adeptus Health's earnings history

Who are Adeptus Health's key executives?

Adeptus Health's management team includes the following people:
  • Gregory W. Scott, Chairman of the Board, Interim Chief Executive Officer
  • Frank Richard Williams Jr, Chief Financial Officer, Executive Vice President
  • Andrew Gervase Jordan, Chief Marketing Officer
  • Traci Bowen, Vice President - Human Resources
  • Andrew Hinkelman, Chief Restructuring Officer
  • Ricardo Martinez M.D., Chief Medical Officer
  • James Muzzarelli, Executive Medical Director
  • Stephen Michael Mengert, Director
  • Ronald L. Taylor, Independent Director
  • Jeffery S. Vender, Independent Director

What is Adeptus Health's stock symbol?

Adeptus Health trades on the OTCMKTS under the ticker symbol "ADPTQ."

What is Adeptus Health's stock price today?

One share of ADPTQ stock can currently be purchased for approximately $1.22.

What is Adeptus Health's official website?

The official website for Adeptus Health is www.adhc.com.

How can I contact Adeptus Health?

Adeptus Health's mailing address is 2941 South Lake Vista, LEWISVILLE, TX 75067, United States. The company can be reached via phone at +1-972-8996666.

This page was last updated on 1/26/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.